Search research articles
Contact Us
Filters
Showing results (31-40 of 228) with videos related to
Page
of 23
Sort By:
Frontiers in Immunology
|
June 17, 2017
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
John P Veluchamy, Nina Kok, Hans J van der Vliet, et al.
Nutrition and Cancer
|
June 16, 2012
Weight loss of 5% or more predicts loss of fat-free mass during palliative chemotherapy in patients with advanced cancer: a pilot study
Susanne Buskermolen, Jacqueline A E Langius, Hinke M Kruizenga, et al.
Biochimica Et Biophysica Acta
|
January 19, 2010
Signalling pathways in vasculogenic mimicry
Yvette W J Paulis, Patricia M M B Soetekouw, Henk M W Verheul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors
Madeleine S Q Kortenhorst, Marianna Zahurak, Shabana Shabbeer, et al.
Biochimica Et Biophysica Acta
|
February 3, 2015
Vaccination approach to anti-angiogenic treatment of cancer
Madelon Q Wentink, Elisabeth J M Huijbers, Tanja D de Gruijl, et al.
Oncoimmunology
|
May 6, 2015
Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy
Inge M Werter, Famke L Schneiders, Emmanuel Scotet, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 9, 2016
Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth
Maria Rovithi, Richard R de Haas, Richard J Honeywell, et al.
Journal of Proteomics
|
December 4, 2008
Proteomics of the TRAP-induced platelet releasate
Sander R Piersma, Henk J Broxterman, Muhammed Kapci, et al.
Cancers
|
November 13, 2020
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance
Richard J Honeywell, Ietje Kathmann, Elisa Giovannetti, et al.
Cells
|
November 10, 2023
Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
Lissa Wullaert, Jan M van Rees, John W M Martens, et al.
Page
of 23
Search research articles
Search
Showing results (31-40 of 228) with videos related to
Sort By:
Page
of 23
Frontiers in Immunology
|
June 17, 2017
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
John P Veluchamy, Nina Kok, Hans J van der Vliet, et al.
Nutrition and Cancer
|
June 16, 2012
Weight loss of 5% or more predicts loss of fat-free mass during palliative chemotherapy in patients with advanced cancer: a pilot study
Susanne Buskermolen, Jacqueline A E Langius, Hinke M Kruizenga, et al.
Biochimica Et Biophysica Acta
|
January 19, 2010
Signalling pathways in vasculogenic mimicry
Yvette W J Paulis, Patricia M M B Soetekouw, Henk M W Verheul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors
Madeleine S Q Kortenhorst, Marianna Zahurak, Shabana Shabbeer, et al.
Biochimica Et Biophysica Acta
|
February 3, 2015
Vaccination approach to anti-angiogenic treatment of cancer
Madelon Q Wentink, Elisabeth J M Huijbers, Tanja D de Gruijl, et al.
Oncoimmunology
|
May 6, 2015
Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy
Inge M Werter, Famke L Schneiders, Emmanuel Scotet, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 9, 2016
Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth
Maria Rovithi, Richard R de Haas, Richard J Honeywell, et al.
Journal of Proteomics
|
December 4, 2008
Proteomics of the TRAP-induced platelet releasate
Sander R Piersma, Henk J Broxterman, Muhammed Kapci, et al.
Cancers
|
November 13, 2020
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance
Richard J Honeywell, Ietje Kathmann, Elisa Giovannetti, et al.
Cells
|
November 10, 2023
Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
Lissa Wullaert, Jan M van Rees, John W M Martens, et al.
Page
of 23